Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 12  •  04:00PM ET
10.07
Dollar change
+1.22
Percentage change
13.71
%
Index- P/E- EPS (ttm)-3.86 Insider Own33.80% Shs Outstand10.50M Perf Week24.54%
Market Cap131.32M Forward P/E- EPS next Y-1.01 Insider Trans0.00% Shs Float8.63M Perf Month31.70%
Enterprise Value106.09M PEG- EPS next Q-0.65 Inst Own6.20% Short Float0.73% Perf Quarter25.62%
Income-49.81M P/S2.47 EPS this Y23.01% Inst Trans0.54% Short Ratio1.01 Perf Half Y124.64%
Sales53.26M P/B0.81 EPS next Y62.73% ROA-22.19% Short Interest0.06M Perf YTD73.71%
Book/sh12.50 P/C4.74 EPS next 5Y- ROE-28.29% 52W High11.99 -15.97% Perf Year122.90%
Cash/sh2.13 P/FCF- EPS past 3/5Y36.93% - ROIC-32.77% 52W Low3.09 225.55% Perf 3Y-82.64%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-51.94% - Gross Margin47.55% Volatility16.27% 7.37% Perf 5Y-
Dividend TTM- EV/Sales1.99 EPS Y/Y TTM30.70% Oper. Margin-94.70% ATR (14)0.79 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.82 Sales Y/Y TTM135.15% Profit Margin-93.53% RSI (14)66.68 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.02 EPS Q/Q-6.79% SMA2024.41% Beta0.16 Target Price14.00
Payout- Debt/Eq0.02 Sales Q/Q197.57% SMA5025.34% Rel Volume3.58 Prev Close8.86
Employees285 LT Debt/Eq0.01 EarningsSep 12 BMO SMA20060.34% Avg Volume61.98K Price10.07
IPOJul 16, 2021 Option/ShortNo / Yes EPS/Sales Surpr.-15.49% -18.53% Trades Volume221,736 Change13.71%
Date Action Analyst Rating Change Price Target Change
Jan-18-23Initiated Cantor Fitzgerald Overweight $7
Sep-12-25 08:30AM
Sep-08-25 11:02AM
Jun-26-25 04:30AM
Jun-18-25 09:10AM
08:51AM
08:45AM Loading…
08:45AM
07:50AM
Jun-13-25 12:15PM
Jun-12-25 08:30AM
Apr-09-25 09:00AM
Mar-18-25 08:30AM
Mar-11-25 08:30AM
Mar-05-25 08:30AM
Feb-11-25 08:30AM
Jan-21-25 08:30AM
08:30AM Loading…
Jan-15-25 08:30AM
Dec-19-24 08:30AM
Dec-06-24 08:30AM
Dec-05-24 08:30AM
Dec-04-24 04:05PM
Nov-27-24 08:30AM
Nov-18-24 06:57AM
06:00AM
Nov-12-24 08:30AM
Oct-30-24 04:15PM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Aug-19-24 08:30AM
Jul-12-24 06:00AM
Jul-11-24 08:30AM
08:30AM Loading…
Jul-01-24 08:30AM
Jun-20-24 06:00AM
Jun-18-24 02:52PM
08:30AM
Jun-17-24 08:30AM
Apr-01-24 01:53PM
07:30AM
Feb-09-24 09:25AM
Nov-20-23 06:00AM
Nov-01-23 06:00AM
Sep-15-23 07:10AM
Aug-29-23 12:46AM
Jun-30-23 08:00AM
Jun-26-23 09:30AM
Jun-25-23 08:45PM
Jun-05-23 07:20AM
Mar-14-23 08:56AM
Mar-02-23 07:00AM
Feb-02-23 04:01PM
Jan-19-23 05:00AM
Jan-17-23 10:00AM
Jan-10-23 08:05AM
Dec-16-22 06:27AM
Nov-30-22 09:15AM
Nov-10-22 08:00AM
Sep-09-22 11:17AM
Aug-12-22 09:34AM
Aug-08-22 04:45AM
Jul-16-22 08:03AM
Jun-08-22 12:56PM
Jun-06-22 09:55AM
May-23-22 12:00PM
08:46AM
May-19-22 12:15PM
May-18-22 06:30PM
May-17-22 11:00AM
Prenetics Global Limited is a health sciences company, which engages in the provision of early detection, prevention, and treatment of cancer. It operates through following segments: Consumer Health, Prevention and Diagnostics. The Consumer Health segment focuses on IM8 a health and wellness brand which focuses on consumer health products and Europa, a U.S. sports distribution company. The Prevention segment focuses on its CircleDNA and ACT Genomics business units. The CircleDNA business unit uses next-generation sequencing (NGS) technology for consumer deoxyribonucleic acid (DNA) test. The Diagnostics segment focuses on ACT Genomics business unit is involved in genomic profiling of solid tumors. It has a presence in the United States. . The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.